Navigation Links
UofL physicians, Jewish Hospital first in Kentucky to offer new aortic valve replacement
Date:1/3/2012

Louisville, Ky. Some individuals with severe aortic stenosis also known as narrowing of the aortic valve in the heart who are not well enough to undergo open heart surgery have a new treatment option thanks to a new procedure now available in Kentucky from University of Louisville physicians at Jewish Hospital.

A team that included UofL cardiologists Michael Flaherty, M.D, Ph.D., and Naresh Solankhi, M.D., and UofL cardiothoracic surgeon Matthew Williams, M.D., performed the first transcatheter aortic-valve replacement (TAVR) procedure on a 47-year-old male patient on Dec. 21, 2011.

During the procedure a biological valve was inserted through a catheter and implanted within a diseased aortic valve. The procedure allows for valve replacement without traditional open-heart surgery and while the heart is beating, therefore avoiding cardiopulmonary bypass.

It is the only valve replacement option for patients with severe aortic stenosis who are not well enough to undergo traditional open-heart surgery, Flaherty said. Most patients will avoid any surgery in their chest.

"For patients who qualify, the TAVR procedure is often their last hope for treatment of their heart disease," said Flaherty, who is assistant professor of medicine, physiology and biophysics and director of research-interventional cardiology in UofL's Department of Medicine. "It's a unique procedure, and we are once again proud to be on the cutting edge of heart care in the region."

During the TAVR procedure, a cardiologist and cardiothoracic surgeon work together to implant the new heart valve, called the Edwards SAPIEN valve, which is made from cow tissue and developed by Edwards Lifesciences Corp.

The valve is inserted into the body through a small cut in the leg. Once delivered to the site of the patient's diseased valve, the Edwards SAPIEN valve is expanded with a balloon and immediately functions in place of the patient's valve.

Jewish Hospital is one of 29 sites in the United States where researchers are now studying the Edwards SAPIEN transcatheter aortic heart valve and the next-generation Edwards SAPIEN XT valve as part of an ongoing national clinical trial called the PARTNER II Trial. The Edwards SAPIEN valve studied in the first PARTNER Trial and used in Europe since 2007 recently received FDA approval for the treatment of inoperable patients in the United States. This is the first U.S. commercial approval for a transcatheter device enabling aortic valve replacement without the need for open-heart surgery.

"The availability of the TAVR procedure marks a major milestone in the treatment of valve-related heart disease," said Williams, who practices with University Cardiothoracic Surgical Associates and is assistant professor of thoracic and cardiovascular surgery in the Department of Surgery at UofL. "It gives us another tool to help take care of people. Older folks, who would prefer to avoid surgery if they can, will be the patients who will most often benefit."


'/>"/>

Contact: Jill Scoggins
jill.scoggins@louisville.edu
502-852-7461
University of Louisville
Source:Eurekalert

Related biology news :

1. Analysis of Ashkenazi Jewish genomes reveals diversity, history
2. NIH awards National Jewish Health $31 million to lead study of infections associated with eczema
3. Gregory Downey, M.D., of National Jewish Health, honored for scientific accomplishments
4. National Jewish Health researchers discover how virulent bacteria
5. New genetic research indicates Jewish priesthood has multiple lineages
6. National Jewish Health researchers evaluating treatment to help emphysema sufferers breathe easier
7. Researchers at National Jewish Health evaluating a treatment
8. New disinfection technique could revolutionize hospital room cleaning
9. Brigham and Womens Hospital awarded $9.6 million to study whole genome sequencing
10. University Hospitals Seidman Cancer Center tests novel drug that makes brain tumors glow hot pink
11. University Hospitals Case Medical Center unlocks mystery of dystonia with advanced imaging
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/14/2016)... AVIV, Israel , April 14, 2016 ... Behavioral Authentication and Malware Detection, today announced the appointment ... already assumed the new role. Goldwerger,s leadership ... BioCatch, on the heels of the deployment of its ... addition, BioCatch,s behavioral biometric technology, which discerns unique cognitive ...
(Date:3/23/2016)... 23, 2016 ... Gesichts- und Stimmerkennung mit Passwörtern     ... MESG ), ein führender Anbieter digitaler ... mit SpeechPro zusammenarbeitet, um erstmals dessen Biometrietechnologie ... die Möglichkeit angeboten, im Rahmen mobiler Apps ...
(Date:3/17/2016)... ABI Research, the leader in transformative ... market will reach more than $30 billion by ... Consumer electronics, particularly smartphones, continue to boost the ... reach two billion shipments by 2021 at a ... Research Analyst at ABI Research. "Surveillance is also ...
Breaking Biology News(10 mins):
(Date:4/29/2016)... 2016 According to a ... "Separation Systems for Commercial Biotechnology Market - Global ... 2015 - 2023", the separation systems for commercial ... in 2014 and is projected to expand at ... to reach US$ 19,227.8 Mn in 2023. ...
(Date:4/29/2016)... -- Elekta is pleased to announce that ... treatment planning software, is available for clinical release. Real-world ... version 5.11 provides significant performance speed enhancements over prior ... four times faster than in previous versions of ... Monte Carlo algorithm, users can ...
(Date:4/28/2016)... ... April 28, 2016 , ... Next week on ... on its first-in-class technologies for tissue stem cell counting and expansion to gene-editing ... to Reprogramming & CRISPR-based Genome Engineering in Burlington, Massachusetts. , The attention of ...
(Date:4/27/2016)... ... April 27, 2016 , ... Shimadzu Scientific Instruments ... Spring 2016 Marijuana Business Conference and Expo. Shimadzu’s high-performance instruments enable laboratories to ... more. Expo attendees can stop by booth 1021 to learn how Shimadzu’s instruments ...
Breaking Biology Technology: